Observational Study on the Treatment of Knee Osteochondral Lesions of Grade III-IV
NCT ID: NCT01554878
Last Updated: 2016-10-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2012-01-31
2014-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multimodal Evaluation of Cartilage Lesions of Patellofemoral Joint
NCT03210584
Triphasic Osteochondral Scaffold for the Treatment of the OCD of the Knee: Observational Study
NCT05332288
Evaluation of Clinical Outcomes of Scaffold Treatment of Partial Meniscal Injuries of the Knee
NCT06475963
Study Protocol to Evaluate Clinical and Imaging Results of Knee Fresh Osteochondral Allografts
NCT04236492
Diagnostic Performance of Ultrasound Imaging Technique for Femoral Condyle Cartilage Evaluation and Osteoarthritis
NCT03184051
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
knee surgery
knee surgery
Reparative, replacement or regenerative techniques, with or without associated osteotomy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
knee surgery
Reparative, replacement or regenerative techniques, with or without associated osteotomy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Axial deviation with chondral damage, correct or not;
* Consent to the processing of personal data, signed and dated by patient;
* Patients of both sexes and aged between 30 and 60 years;
* Patients willing to participate actively in the rehabilitation program and to attend post-operative follow-up visits.
Exclusion Criteria
* BMI\> 30;
* Allergy to collagen or calcium phosphate;
* Patients with neoplastic disease;
* Patients with metabolic disorders, thyroid diseases, immune system disorders.
30 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ettore Sansavini Health Science Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Raul Zini, MD
Role: STUDY_DIRECTOR
Maria Cecilia Hospital
Luisangelo Sordo, MD
Role: PRINCIPAL_INVESTIGATOR
MARIA PIA HOSPITAL
Maurizio Bellettato, MD
Role: PRINCIPAL_INVESTIGATOR
SAN PIER DAMIANO
Andrea Mocci, MD
Role: PRINCIPAL_INVESTIGATOR
ANTHEA HOSPITAL
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Andrea Mocci
Bari, Bari, Italy
Raul Zini
Cotignola, Ravenna, Italy
Maurizio Bellettato
Faenza, Ravenna, Italy
Luisangelo Sordo
Torino, Torino, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ESREFO08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.